Crossmark

An evidence informed framework for artificial intelligence in rare breast cancers using small cohort validation synthetic data practices and clinical governance

Crossref DOI link: https://doi.org/10.1007/s12672-026-05573-1

Published Online: 2026-07-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Alshreef, Bandar Saad https://orcid.org/0009-0009-9284-4262
License Information

Text and Data Mining valid from 2026-07-19

Accepted Manuscript valid from 2026-07-19
More Information

Article History

Received: 30 April 2026

Accepted: 8 July 2026

First Online: 19 July 2026

Declarations

Ethics approval and consent to participate: Ethics approval was not required because this article does not involve human participants, identifiable patient data or animal experiments.

Consent for publication: Not applicable.

Competing interests: The authors declare no competing interests.

Document is current

Any future updates will be listed below